We’ve recently updated our valuation analysis.

Emami Valuation

Is EMAMILTD undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EMAMILTD?

Other financial metrics that can be useful for relative valuation.

EMAMILTD key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue5x
Enterprise Value/EBITDA20.1x
PEG Ratio2.3x

Price to Earnings Ratio vs Peers

How does EMAMILTD's PE Ratio compare to its peers?

The above table shows the PE ratio for EMAMILTD vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average55.4x
507815 Gillette India
44.2xn/a₹146.5b
500459 Procter & Gamble Hygiene and Health Care
78.5x27.3%₹446.8b
500830 Colgate-Palmolive (India)
42.1x9.2%₹440.7b
DABUR Dabur India
56.8x13.7%₹970.2b
27.1x11.6%₹173.1b

Price-To-Earnings vs Peers: EMAMILTD is good value based on its Price-To-Earnings Ratio (27.1x) compared to the peer average (55.4x).


Price to Earnings Ratio vs Industry

How does EMAMILTD's PE Ratio compare vs other companies in the IN Personal Products Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a12.3%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a12.3%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: EMAMILTD is good value based on its Price-To-Earnings Ratio (27.1x) compared to the Indian Personal Products industry average (58.8x)


Price to Earnings Ratio vs Fair Ratio

What is EMAMILTD's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EMAMILTD PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio27.1x
Fair PE Ratio33.2x

Price-To-Earnings vs Fair Ratio: EMAMILTD is good value based on its Price-To-Earnings Ratio (27.1x) compared to the estimated Fair Price-To-Earnings Ratio (33.2x).


Share Price vs Fair Value

What is the Fair Price of EMAMILTD when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EMAMILTD (₹394.4) is trading above our estimate of fair value (₹148.26)

Significantly Below Fair Value: EMAMILTD is trading above our estimate of fair value.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst EMAMILTD forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹394.40
₹482.52
+22.3%
9.7%₹590.00₹410.00n/a23
May ’24₹374.95
₹493.50
+31.6%
11.8%₹660.00₹410.00n/a22
Apr ’24₹358.55
₹501.19
+39.8%
11.2%₹660.00₹419.00n/a21
Mar ’24₹395.05
₹508.26
+28.7%
11.1%₹660.00₹419.00n/a23
Feb ’24₹428.60
₹549.61
+28.2%
8.7%₹660.00₹470.00n/a23
Jan ’24₹425.05
₹559.67
+31.7%
7.6%₹660.00₹470.00n/a24
Dec ’23₹463.55
₹559.67
+20.7%
7.6%₹660.00₹470.00n/a24
Nov ’23₹485.45
₹562.13
+15.8%
9.3%₹668.00₹470.00n/a24
Oct ’23₹504.30
₹560.13
+11.1%
10.1%₹668.00₹470.00n/a24
Sep ’23₹492.20
₹555.87
+12.9%
9.5%₹657.00₹470.00n/a23
Aug ’23₹444.75
₹558.26
+25.5%
10.0%₹657.00₹470.00n/a23
Jul ’23₹426.25
₹557.23
+30.7%
11.1%₹670.00₹465.00n/a22
Jun ’23₹419.00
₹564.25
+34.7%
12.3%₹675.00₹465.00₹387.3520
May ’23₹491.75
₹589.20
+19.8%
11.4%₹715.00₹470.00₹374.9520
Apr ’23₹455.20
₹601.45
+32.1%
11.5%₹715.00₹470.00₹358.5520
Mar ’23₹495.35
₹631.95
+27.6%
7.7%₹715.00₹550.00₹395.0520
Feb ’23₹494.90
₹646.60
+30.7%
6.2%₹730.00₹570.00₹428.6020
Jan ’23₹519.00
₹654.35
+26.1%
5.3%₹730.00₹595.00₹425.0520
Dec ’22₹514.35
₹654.35
+27.2%
5.3%₹730.00₹595.00₹463.5520
Nov ’22₹549.30
₹648.62
+18.1%
6.0%₹730.00₹559.00₹485.4521
Oct ’22₹569.95
₹642.63
+12.8%
5.9%₹690.00₹518.00₹504.3019
Sep ’22₹598.45
₹642.63
+7.4%
5.9%₹690.00₹518.00₹492.2019
Aug ’22₹558.85
₹576.75
+3.2%
6.4%₹630.00₹486.00₹444.7520
Jul ’22₹561.50
₹573.10
+2.1%
6.7%₹630.00₹463.00₹426.2520
Jun ’22₹507.50
₹563.90
+11.1%
7.9%₹610.00₹440.00₹419.0021

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies